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Abstract  
Manual titration of inspired oxygen necessary to adequately respond to respiratory fluctuations of the neonate is 
a challenging task. Furthermore, exposure to high and low levels of oxygen saturations are associated with significant 
morbidity and mortality. Ventilators that automatically control inspired oxygen based on pulse oximeter signals are 
becoming available and seem to be safe and effective when compared to manual control. However, the potential to 
overshoot in response to a hypoxemic episode, thus causing excess hyperoxemia, has not been carefully studied. We 
evaluated the response of one automated FiO2-SpO2 control system to 7,667 desaturations in 21 infants over 113 days. 
We found that the sustained response to desaturations resulted primarily in achievement of normoxemia with balance 
between high and low saturations.  We concluded that this closed loop control system was adequately damped. We suggest 
that this kind of analysis might be helpful is refining control algorithms. 
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Background 
In the neonatal ICU oxygenation is continuously 
monitored noninvasively with the pulse oximeter 
(SpO2). Titration of inspired oxygen (FiO2) in the 
neonatal ICU is a challenging task as sick neonates 
have unstable respiratory systems. Apnea and 
disordered breathing result in frequent episodes of 
hypoxemia. It is generally accepted that these infants 
spend only half the time in the desired SpO2  
target range [1]. Clinicians respond to prolonged 
desaturations with a temporary increase in the inspired 
FiO2. They often do not respond quickly enough not 
only to the need for an increase, but also with a return 
to baseline FiO2 after recovery. The latter increases the 
exposure to hyperoxemia. Importantly exposure to 
SpO2 extremes, high and low, is associated with 
significant morbidity and mortality [2]. 
Systems that automatically control the FiO2, based 
on the SpO2 level (Auto-FiO2) are now available as an 
integral part of some mechanical ventilators [3]. These 
systems are continually vigilant and make adjustments 
as often as every second. In contrast, during manual 
control nurses average about 2–5 adjustments per hour. 
Controlled trials have shown that Auto-FiO2 increases 
the time in the desired SpO2 target range and reduces 
time at SpO2 extremes [4–7]. Examples of the relative 
improvements in oxygenation for the system used in 
this study are shown in Table 1. 
Table 1: Relative Safety and Effectiveness of the AVEA-
CLiO2 according to published studies. 
 [4] [5] [6] [7] 
Number of subjects 32 27 15 80 
% Time Target range     
Auto-FiO2 40% 73% 76% 62% 
RR (Auto/Manual) 1.25* 1.22* 1.10* 1.09* 
% Time Hypoxemia     
Auto-FiO2 4.7% 1.3% 3.1% 0.9% 
RR (Auto/Manual) 0.87 0.40* 0.72 0.41* 
% Time Hyperoxemia     
Auto-FiO2 0.8% 0.1% 6.6% 0.4% 
RR (Auto/Manual) 0.12* 0.05* 0.63* 0.44* 
RR is relative risk. Hypoxemia and hyperoxemia were 
as defined in the study. The former was either <80% or 
<75% [4] SpO2, and the latter either >98% or 
>97% [5] or >96% [6]. Two of the studies [4, 7] were 
multicenter. 
* indicates statistical significance within the study. 
These Auto-FiO2 control systems are classified as 
Physiological Closed Loop Controllers (PCLC) [8]. 
This classification is defined by the use of one 
measured physiological parameter (SpO2) to determine 
the system response/change to the treatment (FiO2). 
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This is in contrast to control systems that measure and 
modify the same parameter; for instance ventilator 
airway pressure or volume. It is difficult to simulate the 
complex physiological domain in which PCLC operate. 
In our case no validated model is available so bench 
tests are of limited value and extensive clinical testing 
is needed to verify safety and effectiveness. 
One important element of the implementation of 
PCLC systems must be consideration of appropriate 
damping of the response to a physiological change. In 
the case of Auto-FiO2 control for neonates, while 
perhaps shortening the degree of hypoxemia, an 
underdamped response to hypoxemia would lead to 
increased hyperoxemia. Both hyperoxemia and 
hypoxemia increase outcomes risk. Further swinging 
from the latter to the former exacerbate the risk by 
causing additional reperfusion injury to the previous 
hypoxic tissues [9]. While studies suggest these Auto-
FiO2 systems are safe and effective [4–7], nothing has 
been published characterizing their specific overshoot 
to hypoxemic episodes. Using data from a recently 
completed clinical study our goal was to document the 
response of one commonly used Auto-FiO2 system to 
hypoxemic episodes. 
Methods 
The response of Auto-FiO2 to hypoxemic episodes 
was extracted from data gathered in a study evaluating 
the frequency of alarms during use of Auto-FiO2 [10]. 
The institution’s Bioethics Committee approved this 
study. The Auto-FiO2 system (AVEA-CLiO2, Vyaire 
Medical, USA) has been in routine clinical use since 
2012 at the study center, the Independent Public 
Hospital of Prof W. Orlowski, in Warsaw Poland. 
The AVEA is a widely used full function mechanical 
ventilator. A summary of the clinical validations of the 
CLiO2 Auto-FiO2 option is provided in Table 1. The 
system is a rules based, multi-parameter, variable gain 
control system. It continuously monitors the SpO2 and 
makes a decision every second whether an adjustment 
in FiO2 should be made. The system’s response 
characteristics are different depending on whether the 
SpO2 is above, below or within the selected control 
range. For SpO2 excursions below the set SpO2 control 
range, which is the focus of this analysis, the magnitude 
of the adjustment is based on 5 metrics. The first 4 are 
the size of the drop below the control range, the 
duration of the drop, the rate of change of SpO2 and 
whether the SpO2 is increasing or decreasing. In 
addition when the SpO2 is recovering (increasing) it 
targets a system derived baseline FiO2 level. The later 
is intended to reduce the probability of overshoot above 
the desired target range into hyperoxemia. Figure 1 
provides examples of the response to desaturations in 
one subject over an 11-minute period. A rapid marked 
increase in FiO2 is evident with significant decreases in 
SpO2. Likewise the decrease in FiO2 towards the 
baseline FiO2 in response to increasing SpO2 is also 
apparent. 
During the study, data was transmitted from the 
ventilator every 5 seconds to an electronic data-logger. 
Endpoints were extracted by purpose-built software. 
Both have been used in other clinical studies. The alarm 
study from which the response data was extracted 
included 21 neonates, evaluated for a total of 113 days. 
 
Fig. 1: Auto-FiO2 Response to changes in SpO2. The 
markers are 5-second data points, the line implies the 
interim values (1-second adjustments). The shaded 
area is the set SpO2 target range. This epoch includes 
one episode of SpO2 <86% and one <80%. It also 
includes the less pronounced adjustments in FiO2 
associated with small changes in SpO2. 
Two levels of potential hypoxemic episodes (HE) 
were prospectively defined. These were: HE<80% 
(hypoxemia, SpO2<80%) and HE<86% (low-oxemia, 
SpO2<86%). Four response categories of oxemia status 
were also prospectively defined: Hypoxemia 
(SpO2<80%) Low-oxemia (SpO2 80–85%), 
Normoxemia (86–96% SpO2) and Hyperoxemia 
(>96% SpO2). 
Two metrics of response were also prospectively 
defined. These were Initial and Sustained. Initial 
response was the first reading after the end of an 
episode and reflects the FiO2 changes made during the 
HE. The Sustained response evaluates the 2 minutes 
after the HE. Sustained identifies the category of 
oxemia associated with greater than 50% of the 
2 minutes following the end of the episode. The latter 
being our primary measure of damping. An episode 
was defined as at least two 5-second data points, that is 
6–9 seconds. Figure 2 illustrated examples of 3 of the 
4 categories of response. 
It should also be noted that more than one episode 
with SpO2<80% could occur in one prolonged episode 
with SpO2 <86%, and that some of the hypoxemic 
responses might not fit into the Sustained definition, in 
that they did not spend at least 60 seconds in any one 
of the 4 oxemia ranges. 
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Fig. 2: Prototypical Examples of Sustained Response. 
The curve with the circles is a Sustained response  
of Hyperoxemia, with an Initial response of 
Normoxemia. The curve with the diamonds is 
a Sustained response of Normoxemia, with an Initial 
response of Normoxemia. The curve with the squares is 
a Sustained response of Low-oxemia, with an Initial 
response of Low-oxemia. The first and third both spend 
part of the time, but less than half, in Normoxemia. 
Data were analyzed using XLSTAT v19.02 
(Addinsoft, Paris, France). Chi2 was used to evaluate 
the differences in the overall response to episodes of 
potential hypoxemia, and z-test to evaluate differences 
in the specific categories of oxemia. A p<0.05 was 
considered to be statistically significant. 
Results  
We identified nearly 10,000 potential hypoxemic 
episodes during the 113 days of the study. Of these we 
were able to categorize the response in nearly  
all (>95%). Thus we evaluated the response to  
7,667 low-oxemic episodes (HE<86%) and 1,819 
hypoxemic episodes (HE<80%). The median (IQR) of 
the rate of HE<86% was 1.82/hour (1.13–2.76) and for 
HE<80%, 0.29/hour (0.16–0.45). The median inspired 
oxygen of the infants varied among the days (range 
FiO2: 22.4–53.2%). The SpO2 was well maintained 
(daily median, range 90.4–95.5% SpO2), with 95% of 
the time spent in normoxemia. 
The Initial and Sustained response to HE<86% and 
HE<80% are shown in Tables 2 and 3 respectively. In 
both cases the Initial response is clearly different than 
the Sustained response (p<0.001). As seen in Table  
2 the initial response to episodes of HE<86% is almost 
entirely Normoxemia (86–96% SpO2). In the two 
minutes of continued response most (86% of episodes) 
remain normoxemic with some moving higher and 
some lower. As seen in Table 3 the response to 
HE<80% is similar. That is, the Initial response to 
episodes is primarily (84% of episodes) 80–85% SpO2, 
with some (15%) also initially in normoxemia. In the 
two minutes of continued response to HE<80% most 
(58% of episodes) became normoxemic with some 
moving to higher and some to lower levels of SpO2. 
Table 2: Categorization of Response to 7,667 episodes 
of SpO2 <86%. 
oxemia hypo low  norm hyper 
Initial na na 99.7% 0.3% 
Sustained 1.4% 9.1% 85.9% 3.6% 
Table 3: Categorization of Response to 1,819 episodes 
of SpO2 <80%. 
oxemia hypo low  norm hyper 
Initial na 84.3% 15.4% 0.4% 
Sustained 5.3% 29.8% 57.7% 7.3% 
For purposes of comparison between HE<86% and 
HE<80% the same data is presented graphically, in 
Fig. 3 for the Sustained response. The two minutes of 
continued Sustained control reflect a similar balanced 
distribution, although the difference is statistically 
significant, p<0.001. Further the responses to 
hypoxemia result in a higher incidence of hyperoxemia 
and hypoxemia for HE<80% (7.25% and 5.25% 
respectively) than for HE<86% (3.63% and 1.37% 
respectively), p<0.001. 
 
Fig. 3: Sustained Response Status after Episodes 
<80% and <86% SpO2. 
Discussion  
We evaluated nearly 10,000 responses of an Auto-
FiO2 system to two levels of SpO2 desaturations 
(HE<86% and HE<80%) that occurred in 21 neonates 
over 113 days. We found that in the two-minute period 
following the desaturation the SpO2 level 
predominately reflected normoxemia and that the 
presence of hypoxemia or hyperoxemia was infrequent 
and balanced. However, the incidence of hyperoxema 
was markedly higher when recovering from HE<80%, 
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suggesting a more aggressive response of the algorithm 
to more significant desaturations. This effect was also 
apparent in the Initial response. We are unaware of any 
similar data from testing of this or any other Auto-FiO2 
system. 
One study did characterize the response of SpO2 to 
single manual step increases and decreases in FiO2 
[11]. They found a typical 36–40 second 95%-response 
to a change. However, the response varied significantly 
among episodes, but most would be consistent with our 
2-minute evaluation window. A review of Fig. 1 and 2 
suggests that the two-minute window for Sustained 
response is adequate to capture an over or undershoot 
in response to a desaturation. During manual titration 
of FiO2 clinicians are encouraged to wait to make an 
adjustment to insure the desaturation is persistent and 
then after an adjustment, to focus on the response 
before making another adjustment. This full step 
response noted above is much longer than the 1-second 
adjustments of the Auto-FiO2 system and even the 
5-second data epochs we evaluated. This Auto-FiO2 
approach is in obvious contrast to the standard practice 
for manual adjustments. One should expect that this 
could lead to less stable SpO2 if the controller was 
underdamped. In one early study where SpO2 stability 
was evaluated, the coefficient of variation of SpO2 was 
reduced during Auto-FiO2 and the duration of episodes 
of significant hypoxemic episodes and hyperoxemic 
episodes were shorter, suggesting the potential for 
overshoot is appropriately addressed [4]. 
During manual control of FiO2 most episodes of 
hypoxemia are short and resolve without intervention. 
However, when episodes are prolonged, the increase in 
FiO2 is generally appropriate, but there is often a failure 
to promptly wean the FiO2 back to a baseline level. In 
a study of manual FiO2 control, Van Zanten et al 
showed hyperoxemia occurred in 79% of the responses 
to marked hypoxemia [12]. These resulting episodes of 
hyperoxemia were very prolonged with a median 
duration of 13 minutes. While an Auto-FiO2 system 
does not forget to wean, they should be designed to 
wean slowly to avoid a swing back to hypoxemia. Van 
Zanten also reported, that during manual control, when 
the FiO2 was weaned back to baseline within 2–3 
minutes hyperoxemia was rare. Studies of this Auto-
FiO2 system have shown that prolonged episodes of 
hyperoxemia are infrequent [4–6]. It is unclear how 
much of the hyperoxemia seen during the use of this 
system is due to a short term transient overshoot in the 
first 2 minutes or weaning from hyperoxemia once 
established. Our analysis was not designed to evaluate 
response to hyperoxemic episodes. However, we 
speculate that while both are relevant factors, longer 
term weaning and not overshoot is the main 
contributor. This could be addressed in future analyses. 
Studies of this Auto-FiO2 system have consistently 
shown a marked reduction in hyperoxemia when  
 
 
compared to routine manual adjustment of FiO2 
(Table 1). While this supports the effectiveness of 
Auto-FiO2 at reducing hyperoxemia, it speaks more to 
the inadequacy of manual control. However, three 
multicenter studies have also suggested that the set 
control range might also impact the relative risk of 
hyperoxemia [7, 13, 14]. The report of van Kaam et al 
showed an increase in hyperoxemia associated with 
a higher target range (91–95%) as compared to a lower 
(89–93%). This effect was present in both Manual and 
Automated control. In the van den Heuvel study of 
three different automatically controlled target ranges 
with the same midpoint, there was a trend toward 
increased hyperoxemic episodes with a narrower target 
range. This suggested the possibility of increased 
overshoot with a narrower control range. The report of 
Wilinska et al is consistent with the findings of both. 
Therefore, it is not settled as to what degree that 
increased hyperoxemia, when using this Auto-FiO2, is 
associated with a narrowing or a shift of target range. 
We speculate that the frequency of hyperoxemic 
episodes associated with both the stability of the infant 
and the selected target range, as well as the propensity 
of increased overshoot with narrower target ranges are 
both factors. In this analysis the target range was fairly 
wide (88–95%). We suggest that additional evaluation 
of these factors is warranted. 
Our analysis has some limitations. Different 
definitions of the ranges of oxemia would lead to 
different results. However, we believe the trend and 
conclusions would be consistent. Further the categories 
of oxemia we selected are consistent with PaO2 levels 
[15]. Finally, it is possible that less stable subjects 
might result in exacerbated responses. These were 
particularly stable patients, with only 3–4 episodes per 
hour. In a clinical study of subjects selected because 
they were unstable, the incidence was 5 times higher 
[4]. In such cases it is possible that the Sustained 
evaluation period would be confounded with 
subsequent hypoxemic episodes. Even with these more 
stable subjects the Sustained time period of 2 minutes 
is probably confounded to some degree by ongoing 
physiological variation. 
Conclusion  
We found no evidence of significant overshoot from 
hypoxemia to hyperoxemia in this group of subjects 
with this Auto-FiO2 system. In the two minutes 
following recovery, the risk of hypoxemia and 
hyperoxemia were low and balanced. This suggests 
that the control system is appropriately damped to 
address physiological variability. We suggest that 
further evaluation of specific response characteristics 
might be helpful in testing and refining Auto-FiO2 
control algorithms. 
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